Skip to main content
Article thumbnail
Location of Repository

Institutional change, innovation and regulation failure: evidence from the Spanish drug market

By Joan Costa-i-Font and Jaume Puig-Junoy


Scant evidence has been reported on the influence of institutional change in drug market regulation. This article draws on the evidence of Spanish drug regulation (1980-2005) with the aim of examining whether institutional (lack of) change affected (i) regulatory innovation and (ii) the propensity of regulatory failure (rent seeking). We find that the prevailing institutional design of Spanish drug regulation has been prone to regulatory failure as incentives were geared towards rent-seeking behaviour and inefficient drug use by older patients and doctors. Innovation was typically imported except for a government devolution which occasionally has prevented regulatory failure

Topics: HC Economic History and Conditions, DP Spain, RA Public aspects of medicine
Year: 2007
DOI identifier: 10.1332/030557307782452994
OAI identifier:
Provided by: LSE Research Online
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.